Owlstone Medical delivers breath biopsy test data
Preliminary data has shown excellent safety, while also demonstrating proof of mechanism
Read More
Tag: Owlstone
Owlstone Medical collaborates with Bicycle Therapeutics
Duo team up for the development of antigen-targeted probes for early cancer detection
Read More
Owlstone, Thermo Fisher team up for early disease detection
If successful, Thermo’s mass analyser will become a standard part of Owlstone Medical’s biomarker discovery process.
Read More
Owlstone Medical, Actelion team up for pulmonary hypertension detection
Currently, early diagnosis of PH is very difficult and a delay of years between the onset of symptoms and diagnosis and treatment is unfortunately common.
Read More
GSK to use Owlstone’s breath biopsy in COPD trial
In a major boon for UK diagnostics group Owlstone Medical, GlaxoSmithKline is incorporating the firm’s Breath Biopsy platform into the clinical development programme for its novel, experimental respiratory drug danirixin.
Read More
Owlstone Medical, CR UK test potential of breath test for cancer
UK diagnostics group Owlstone Medical and Cancer Research UK have kicked off a study aiming to identify breath biomarkers to improve the early detection and diagnosis of multiple cancer types.
Read More
UK launch for world’s largest breath-based study into bowel cancer
UK diagnostics group Owlstone Medical has kicked off a 1,400 patient clinical trial assessing the potential of its FAIMS (Field Asymmetric Ion Mobility Spectrometer) technology in the early detection of colorectal cancer, which it claims to be the world’s largest breath-based study into the disease.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
